cbd and glp-1 medications get at the heart of addiction: study – WashU Medicine Blockade of cannabinoid 1 receptor

Many Chicago patients ask the same question: Is it safe to drink while taking GLP-1 medications

The landmark cardiovascular outcomes trialsincluding SUSTAIN-6 for semaglutide and LEADER for liraglutidespecifically evaluated cardiovascular safety endpoints and did not report increased rates of venous thromboembolism compared to placebo, though it's important to note that VTE was not a primary endpoint in these studies

Commensal bacteria direct selective cargo sorting to promote symbiosis

An Open-Label Clinical Trial to Investigate the Efficacy and Safety of Corifollitropin Alfa Combined With hCG in Adult Men With Hypogonadotropic Hypogonadism

L.MehtaA.RosensonR